Killing of resistant cancer cells with low bak by a combination of an antimesothelin immunotoxin and a TRAIL receptor 2 agonist antibody

Xing Du, Laiman Xiang, Crystal Mackall, Ira Pastan

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Killing of resistant cancer cells with low bak by a combination of an antimesothelin immunotoxin and a TRAIL receptor 2 agonist antibody'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases